Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin-19 contributes as a protective factor in experimental Th2-mediated colitis.

Naunyn-Schmiedeberg's archives of pharmacology - 1 Mar 2017

Fujimoto Yasuyuki, Azuma Yasu-Taka, Matsuo Yukiko, Kuwamura Mitsuru, Kuramoto Nobuyuki, Miki Mariko, Azuma Naoki, Teramoto Midori, Nishiyama Kazuhiro, Izawa Takeshi, Nakajima Hidemitsu, Takeuchi Tadayoshi

Abstract excerpt

Inflammatory bowel disease results from chronic dysregulation of the mucosal immune system and aberrant activation of both the innate and adaptive immune responses. IL-19 is a member of the IL-10 family, and IL-10 plays an important role in inflammatory bowel disease. We have previously shown that IL-19 knockout mice are more susceptible to innate-mediated colitis. Next, we ask whether IL-19 contributes to T...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interleukins
Share to Lymph Nodes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colitis

Share to Inflammation Mediators

Share to Interleukin-10

Share to Protective Factors

Share to Th2 Cells

Source

Identifiers

PMID: 27942772
DOI: 10.1007/s00210-016-1329-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-19 contributes as a protective factor in experimental Th2-mediated colitis.PMID 27942772Read ↗

Interleukin-19 protects mice from innate-mediated colonic inflammation.Semantic proximity Read ↗

Interleukin-19 Is a Negative Regulator of Innate Immunity and Critical for Colonic ProtectionSemantic proximity Read ↗

Eosinophil-derived COX-2 protects against experimental colitis through the PGE <sub>2</sub> -IL-22 axisSemantic proximity Read ↗

Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.Semantic proximity Read ↗

Cutting edge: regulation of intestinal inflammation and barrier function by IL-17C.Semantic proximity Read ↗

Interleukin-19: Multiple roles in immune regulation and diseaseSemantic proximity Read ↗

Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice.Semantic proximity Read ↗

Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.Semantic proximity Read ↗

Interleukin-17 induces an atypical M2-like macrophage subpopulation that regulates intestinal inflammation.Semantic proximity Read ↗

Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in miceSemantic proximity Read ↗

Role of miR-19a targeting TNF-α in mediating ulcerative colitisSemantic proximity Read ↗

NHE3 modulates the severity of colitis in IL-10-deficient mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.